TCL Archive Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint March 29, 2013
TCL Archive Cancer & The Media: Klausner, Watson Dispute Comments In New York Times Story May 8, 1998
TCL Archive Pharmaceutical Industry: IVAX Official Broder Objects To Orphan Drug Policies of FDA May 9, 1997